HORIBA UK Ltd. is pleased to welcome back Dr. Simon FitzGerald to its Scientific team in the role of Technical Manager. He will lead the company’s team of application and product specialists to help further HORIBA’s position as a world-leading manufacturer of spectroscopic instrumentation. Dr. FitzGerald will also work closely with users across the United […]

Change is taking place at the top of the Endress+Hauser Group. Effective 1 March 2019, Dr Andreas Mayr will become Chief Operating Officer (COO) responsible for sales, production and support, thus assuming more responsibility on the Executive Board. In this function he will serve as deputy CEO to Matthias Altendorf. On 1 October 2018, Jörg Stegert joined […]

SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more than 25 years of executive and financial leadership experience […]

NEW YORK – Nov. 15, 2018 – Schrödinger, a privately held company revolutionizing drug discovery and materials design through advanced molecular simulations, today announced the appointment of veteran pharmaceutical executive Joel Lebowitz as chief financial officer. Mr. Lebowitz, a longtime senior executive at Merck, brings to the company deep experience in finance and business development. “Joel […]

BERWYN, Pa. — AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has elected Keith Reazin as Vice President and General Manager, Instrumentation and Specialty Controls Division. “I am very pleased to announce Keith’s promotion to Vice President and General Manager,” comments David A. Zapico, AMETEK Chairman and Chief Executive Officer. “Keith brings to his new position a strong operational background […]

At the ordinary General Meeting on December 5, 2018, the Board of Directors of Datacolor AG will propose that Hanno Elbraechter (1980), be elected as a new member of the Board of Directors.   Hanno Elbraechter studied Marketing, Finance and Business Law in European Business Program (EBP) at the Ecole de Management (ESC) de Bordeaux, France […]

Company creates U.S. subsidiary and adds Dr. Jeffrey Jeddeloh as VP of Business Development, Commercial Strategy, Dr. Stephen Macevicz as VP of IP and Dr. Christine Peponnet as VP of Technology Development. PARIS and CAMBRIDGE, Mass. – DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced the creation of DNA Script […]